Georgetown Lombardi, Washington's only National Cancer Institute-designated Comprehensive Cancer Center, works with other institutions - MedStar Health and the John Theurer Cancer Center - to broaden its research capacity.
We are developing and testing the cancer treatments of tomorrow - targeted therapies that will improve both survival and quality of life.
Award-winning physicians, state-of-the-art facilities, and a high commitment to excellence—qualities that make Lombardi stand out above the rest!
Educating and training tomorrow's leaders in cancer treatment and research is our mission.
Discover what distinguishes Georgetown Lombardi Comprehensive Cancer Center,
Washington, D.C.’s only National Cancer Institute-designated Comprehensive Cancer Center.
Georgetown University President John J. DeGioia discusses the significance of Georgetown Lombardi's research.
Meet 
Georgetown University Medical Center (GUMC) is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through MedStar Health).
OncLive
OncLive and Georgetown Lombardi collaborate through OncLive's Strategic Alliance Partnership initiative.
Lombardi News Stories
-
First Patient in a Clinical Trial Using Her Own Blood to Personalize Treatment for Non-Hodgkin Lymphoma Experiencing Remission
-
Movement for Multiple Sclerosis (MS) Program
-
Giving Patients a Voice in Breast Cancer Research
-
Georgetown Genetic Counselor Offers Insight on Direct-to-Consumer DNA Testing Kits